Just as I predicted. Violently up and down. Here on out should hold and volume is decent for the time being. Could start to fade if we close under $.24. If it is true FDA approval on the way along with upbeat earnings report to keep the company afloat could easily see another 60% upside before earnings.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.